Tickerplace logo

Tickerplace

Oruka Therapeutics, Inc. logo

ORKAOruka Therapeutics, Inc.

ORKA Stock Price, Valuation & Chart | Oruka Therapeutics, Inc.

Compare
$78.190-2.16 (-2.69%)

At close · 13 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

ORKA Historical price chart

ORKA Key Stats

Market Capitalization4.72B
PE Ratio-40.3
EPS-1.94
Trading Volume490.80K
Today's High/Low80.19/78.19
Dividend Yield0.00
52 Week High/Low115.52/24.88
Shares Outstanding60.31M
ORKA Financial Statement
ORKA Analyst ratings
ORKA Analysis & performance metrics

ORKA Company profile

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline…

ORKA Management team

Management
Alan Lada
Vice President of Investor Relations
Rajiv Panwar
Vice President and Head of Chemistry, Manufacturing & Controls
Joe Senn Ph.D.
Senior Vice President of Nonclinical Research & Development
Paul T. Quinlan
General Counsel & Secretary
Laura Sandler
Senior Vice President of Operations & Boston Site Head
Arjun Agarwal CPA
Senior Vice President of Finance & Treasurer
Christopher Finch
Vice President of Corporate Development & Strategy
Joana Goncalves M.D.
Chief Medical Officer
Total 8 executives

ORKA Frequently asked questions

What is Oruka Therapeutics, Inc. (ORKA) Stock Price?

Current stock price of Oruka Therapeutics, Inc. (ORKA) stock is $78.190. The stock price is -2.69% lower in the session. The intraday range can be seen from this page. Volume of Oruka Therapeutics, Inc. (ORKA) stock is 490.80K.

Last updated at 13 Oct 2026, 08:00 pm.

Why is the Oruka Therapeutics, Inc. (ORKA) stock price going up or down today?

The stock price of Oruka Therapeutics, Inc. (ORKA) can change with earnings, company news, and overall market sentiment. Oruka Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Oruka Therapeutics, Inc. stock expensive at its current price?

Whether Oruka Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ORKA on this page is -40.30. EPS on this page is -1.94. Compare those figures with peers and growth expectations before deciding if the current Oruka Therapeutics, Inc. price is justified.

How has the stock price of Oruka Therapeutics, Inc. (ORKA) performed historically?

Historical performance for Oruka Therapeutics, Inc. (ORKA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ORKA reacted to past earnings and market events.

Should I buy Oruka Therapeutics, Inc. (ORKA) stock, at this price?

Buying Oruka Therapeutics, Inc. (ORKA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.